<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To describe clinical characteristics of <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease in Tunisia </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: It's a retrospective and multicentric study conducted by the Tunisian society of internal medicine </plain></SENT>
<SENT sid="2" pm="."><plain>Inclusion criteria were those of the international study group </plain></SENT>
<SENT sid="3" pm="."><plain>Were also included patients without international study group criteria but with at least one manifestation among <z:hpo ids='HP_0001369'>arthritis</z:hpo>, <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> or neurological manifestation with oral and <z:e sem="disease" ids="C0151281" disease_type="Disease or Syndrome" abbrv="">genital ulceration</z:e> or <z:e sem="disease" ids="C0149745" disease_type="Disease or Syndrome" abbrv="">oral ulceration</z:e> and <z:mp ids='MP_0001212'>skin lesions</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Five hundred and nineteen patients were included </plain></SENT>
<SENT sid="5" pm="."><plain>87.5% of them fulfilled the international criteria </plain></SENT>
<SENT sid="6" pm="."><plain>The male to female ratio was 2,7 </plain></SENT>
<SENT sid="7" pm="."><plain>The mean age was 28.7+/-9.3 years at <z:hpo ids='HP_0003674'>onset</z:hpo> and 32.7+/-9.2 years at diagnosis </plain></SENT>
<SENT sid="8" pm="."><plain>The incidence of each manifestations was as follows: <z:hpo ids='HP_0000155'>oral ulcers</z:hpo>: 100%, <z:hpo ids='HP_0003249'>genital ulcers</z:hpo>: 87.5%, pseudo-<z:mp ids='MP_0000376'>folliculitis</z:mp>: 67.6%, <z:hpo ids='HP_0010783'>erythema</z:hpo> nodosum: 17.5%, positive <z:e sem="disease" ids="C0878631" disease_type="Disease or Syndrome" abbrv="">pathergy</z:e> test: 51%, joint involvement: 55%, <z:hpo ids='HP_0000554'>uveitis</z:hpo>: 32.2%, vein <z:mp ids='MP_0005048'>thrombosis</z:mp>: 24.9%, arterial <z:hpo ids='HP_0002617'>aneurysms</z:hpo>: 3.9%, neurological involvement: 11.6% </plain></SENT>
<SENT sid="9" pm="."><plain>The frequency of HLA B51 antigen was 35% among the 187 patients tested </plain></SENT>
<SENT sid="10" pm="."><plain>There was no difference in the manifestations of the disease between patients having B51 and those lacking it </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0004936'>Venous thrombosis</z:hpo> (29.8 vs 11.4%), arterial involvement (4.4 vs 1.4%) and <z:hpo ids='HP_0000554'>uveitis</z:hpo> (37.5 vs 17,9%) were significantly more frequent in men whereas <z:hpo ids='HP_0010783'>erythema</z:hpo> nodosum (22.9% vs 15.6%) and joint involvement (70,7 vs 49.9%) more frequent in women </plain></SENT>
<SENT sid="12" pm="."><plain>The mean follow up was 6,1+/-5.7 years </plain></SENT>
<SENT sid="13" pm="."><plain>Mortality rate was 2.3% in our series </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSION: Our study confirms the androtropism of the disease in Mediterranean and Middle east countries </plain></SENT>
<SENT sid="15" pm="."><plain>Positive <z:e sem="disease" ids="C0878631" disease_type="Disease or Syndrome" abbrv="">pathergy</z:e> test and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> were more frequent in our study, like those from Mediterranean region </plain></SENT>
<SENT sid="16" pm="."><plain>Whereas, ocular and neurological involvement were quite less frequent in our series </plain></SENT>
</text></document>